vs
Ispire Technology Inc.（ISPR）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Ispire Technology Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.7倍（$20.3M vs $11.6M），SUTRO BIOPHARMA, INC.同比增速更快（-21.4% vs -51.5%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -17.8%）
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业，主要服务尼古丁及合法大麻消费市场，下设硬件、品牌大麻产品两大核心业务板块，覆盖北美、欧洲、亚太等核心市场，为B端合作商及终端用户提供合规创新的雾化解决方案。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
ISPR vs STRO — 直观对比
营收规模更大
ISPR
是对方的1.7倍
$11.6M
营收增速更快
STRO
高出30.1%
-51.5%
两年增速更快
STRO
近两年复合增速
-17.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.3M | $11.6M |
| 净利润 | $-6.6M | — |
| 毛利率 | 17.1% | — |
| 营业利润率 | -33.9% | — |
| 净利率 | -32.5% | — |
| 营收同比 | -51.5% | -21.4% |
| 净利润同比 | 17.4% | 35.4% |
| 每股收益（稀释后） | $-0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPRSTRO
| Q4 25 | $20.3M | $11.6M | ||
| Q3 25 | $30.4M | $9.7M | ||
| Q2 25 | $20.1M | $63.7M | ||
| Q1 25 | $26.2M | $17.4M | ||
| Q4 24 | $41.8M | $14.8M | ||
| Q3 24 | $39.3M | $8.5M | ||
| Q2 24 | $37.3M | $25.7M | ||
| Q1 24 | $30.0M | $13.0M |
净利润ISPRSTRO
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-3.3M | $-56.9M | ||
| Q2 25 | $-14.8M | $-11.5M | ||
| Q1 25 | $-10.9M | $-76.0M | ||
| Q4 24 | $-8.0M | $-72.4M | ||
| Q3 24 | $-5.6M | $-48.8M | ||
| Q2 24 | $-3.5M | $-48.0M | ||
| Q1 24 | $-5.9M | $-58.2M |
毛利率ISPRSTRO
| Q4 25 | 17.1% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 18.2% | — | ||
| Q4 24 | 18.5% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 28.3% | — | ||
| Q1 24 | 20.4% | — |
营业利润率ISPRSTRO
| Q4 25 | -33.9% | — | ||
| Q3 25 | -8.9% | -499.9% | ||
| Q2 25 | -72.7% | -5.2% | ||
| Q1 25 | -40.4% | -393.8% | ||
| Q4 24 | -17.6% | -440.7% | ||
| Q3 24 | -13.4% | -797.2% | ||
| Q2 24 | -9.2% | -189.4% | ||
| Q1 24 | -18.8% | -435.0% |
净利率ISPRSTRO
| Q4 25 | -32.5% | — | ||
| Q3 25 | -10.7% | -586.6% | ||
| Q2 25 | -73.4% | -18.0% | ||
| Q1 25 | -41.5% | -436.6% | ||
| Q4 24 | -19.1% | -489.2% | ||
| Q3 24 | -14.2% | -572.6% | ||
| Q2 24 | -9.4% | -186.8% | ||
| Q1 24 | -19.7% | -447.5% |
每股收益（稀释后）ISPRSTRO
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-0.06 | $-0.67 | ||
| Q2 25 | $-0.26 | $-0.14 | ||
| Q1 25 | $-0.19 | $-0.91 | ||
| Q4 24 | $-0.14 | $-27.63 | ||
| Q3 24 | $-0.10 | $-0.59 | ||
| Q2 24 | $-0.07 | $-0.59 | ||
| Q1 24 | $-0.11 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.6M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-7.7M | $-132.5M |
| 总资产 | $84.4M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISPRSTRO
| Q4 25 | $17.6M | $141.4M | ||
| Q3 25 | $22.7M | $167.6M | ||
| Q2 25 | $24.4M | $205.1M | ||
| Q1 25 | $23.5M | $249.0M | ||
| Q4 24 | $34.4M | $316.9M | ||
| Q3 24 | $37.7M | $388.3M | ||
| Q2 24 | $35.1M | $375.6M | ||
| Q1 24 | $39.5M | $267.6M |
股东权益ISPRSTRO
| Q4 25 | $-7.7M | $-132.5M | ||
| Q3 25 | $-1.8M | $-87.3M | ||
| Q2 25 | $604.7K | $-32.1M | ||
| Q1 25 | $14.8M | $-25.8M | ||
| Q4 24 | $24.2M | $44.6M | ||
| Q3 24 | $30.7M | $111.2M | ||
| Q2 24 | $34.5M | $152.2M | ||
| Q1 24 | $35.9M | $98.0M |
总资产ISPRSTRO
| Q4 25 | $84.4M | $173.8M | ||
| Q3 25 | $96.4M | $209.7M | ||
| Q2 25 | $102.2M | $262.4M | ||
| Q1 25 | $115.7M | $321.4M | ||
| Q4 24 | $132.0M | $387.2M | ||
| Q3 24 | $129.0M | $451.8M | ||
| Q2 24 | $122.6M | $489.0M | ||
| Q1 24 | $108.0M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | — |
| 自由现金流率自由现金流/营收 | -19.9% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.2M | — |
8季度趋势，按日历期对齐
经营现金流ISPRSTRO
| Q4 25 | $-4.0M | $-177.2M | ||
| Q3 25 | $-1.2M | $-38.2M | ||
| Q2 25 | $4.7M | $-44.7M | ||
| Q1 25 | $-12.5M | $-67.9M | ||
| Q4 24 | $-3.2M | $-71.7M | ||
| Q3 24 | $3.6M | $-64.5M | ||
| Q2 24 | $-1.4M | $9.5M | ||
| Q1 24 | $3.4M | $-64.7M |
自由现金流ISPRSTRO
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $-12.7M | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $-2.2M | — | ||
| Q1 24 | $3.3M | — |
自由现金流率ISPRSTRO
| Q4 25 | -19.9% | — | ||
| Q3 25 | -3.9% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | -48.4% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | -5.9% | — | ||
| Q1 24 | 10.9% | — |
资本支出强度ISPRSTRO
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 0.3% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
